Source comparison
MK-677 Subq vs Oral Administration: Research Method Comparison
Subcutaneous Injection ~95% (bypasses first-pass metabolism) 30–60 minutes to peak plasma levels Moderate. Site rotation prevents lipohypertrophy; sterile technique required High. Requires reconstitution, sterile supplies, injection training Preferred for PK/P
This comparison does not assign a generated winner or score.
- Subcutaneous Injection
- ~95% (bypasses first-pass metabolism)
- 30–60 minutes to peak plasma levels
- Moderate. Site rotation prevents lipohypertrophy; sterile technique required
- High. Requires reconstitution, sterile supplies, injection training
- Preferred for PK/PD studies requiring precise dosing and plasma sampling
- Oral Capsule/Tablet
- 60–70% (subject to hepatic first-pass)
- 60–90 minutes to peak plasma levels
- None
- Low. No reconstitution or injection required
- Preferred for behavioral studies, long-term feeding protocols, or non-invasive dosing
- Intramuscular Injection
- ~95% (similar to subq)
- 20–40 minutes (faster absorption than subq)
- Higher. Deeper injection increases pain, bruising risk
- High. Same sterile technique and reconstitution as subq
- Used when rapid onset is required or when subq sites are exhausted
- Professional Assessment
- Subcutaneous injection offers bioavailability nearly equal to IM with less pain and easier self-administration. Oral dosing sacrifices 25–30% bioavailability but eliminates injection-site complications and simplifies protocols where exact PK is less critical. For multi-week research requiring dose precision and minimal variability, subq remains the standard.